Endothelin as a therapeutic target in the treatment of cardiovascular disease.
about
Tezosentan in the treatment of acute heart failure.Application of structure-metabolism relationships in the identification of a selective endothelin A antagonist, BMS-193884, with favourable pharmacokinetic properties.Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension.Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model.
P2860
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
@ast
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
@en
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
@nl
type
label
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
@ast
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
@en
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
@nl
prefLabel
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
@ast
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
@en
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
@nl
P2093
P1476
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
@en
P2093
P304
P356
10.1097/00132580-200105000-00008
P577
2001-05-01T00:00:00Z